Listeria monocytogenes multifocal cerebritis in an immunocompetent adult

Branko Milošević; Aleksandar Urošević; Nataša Nikolić; Ivana Milošević; Jasmina Poluga; Tanja Tošić; Milica Jovanović

doi:10.2298/VSP180619146M

Branko Milošević University of Belgrade, Faculty of Medicine
Aleksandar Urošević Clinical Center of Serbia, Clinic for Infectious and Tropical Diseases
Nataša Nikolić Clinical Center of Serbia, Clinic for Infectious and Tropical Diseases
Ivana Milošević Clinical Center of Serbia, Clinic for Infectious and Tropical Diseases
Jasmina Poluga Clinical Center of Serbia, Clinic for Infectious and Tropical Diseases
Tanja Tošić Clinical Center of Serbia, Department of Microbiology
Milica Jovanović Clinical Center of Serbia, Department of Microbiology

DOI: https://doi.org/10.2298/VSP180619146M

Keywords: meningitis, listeria;, listeriosis;, anti-infective agents;, drug combinations;, tomography;, trimetoprim, sulfamethoxazole drug combination

Abstract

Introduction. Multifocal cerebritis is a rare and severe disease and just a several cases caused by Listeria monocytogenes were described in the literature. Case report. A 64 year old man was admitted to the hospital with disturbed consciounsness (Glasgow Coma Scale score: 9) after being febrile for 16 days with history of fever, headache and middle ear pain. He did not have any other comorbidities neither he was immunocompromised. Penicillin allergy was noted for him. On neurologic exam, meningeal or focal neurologic signs were not evident, but computed tomography (CT) brain scan with contrast injection showed 3 hypodense zones in the occipital and 1 in the right temporal lobe. Laboratory findings in blood and cerebrospinal fluid (CSF) were indicative for the infectious nature of changes in the endocranium (multifocal cerebritis). Initial therapy was the combination of cefotaxime, amikacin and metronidazole, but after the isolation of L. monocytogenes from CSF and blood culture, therapy was switched to co-trimoxazole. Recovery of consciouscness with establisment of alert state occurred after 6 days of co-trimoxazole administration. Total therapy took 36 days. During that period all clinical and laboratory parameters normalized. The patient was discharged as recovered, with sequelas of amnesia and slurring of speech. Conclusion. In the treatment of multifocal cerebritis caused by L. monocytogenes, adequate choice and long-term therapy with antibiotics are necessary. The drug of choice is ampicillin but in the case of allergy to it, co-trimoxazole is a good replacement.

References

Cone LA, Leung MM, Byrd RG, Annunziata GM, Lam RY, Herman BK. Multiple cerebral abscesses because of Listeria monocytogenes: three case reports and a literature review of supratentorial listerial brain abscess(es). Surg Neurol 2003; 59(4): 320–8.

Watson GW, Fuller TJ, Elms J, Kluge RM. Listeria cerebritis: re-lapse of infection in renal transplant patients. Arch Intern Med 1978; 138(1): 83–7.

Haykal H, Zamani A, Wang A, Barsotti J. CT features of early Listeria monocytogenes cerebritis. AJNR Am J Neuroradiol 1987; 8(2): 279–82.

Salata RA, King RE, Gose F, Pearson RD. Listeria monocyto-genes cerebritis, bacteremia, and cutaneous lesions complicat-ing hairy cell leukemia. Am J Med 1986; 81(6): 1068–72.

Aladro Y, Ponce P, Santullano V, Angel-Moreno A, Santana MA. Cerebritis due to Listeria monocytogenes: CT and MR find-ings. Eur Radiol 1996; 6(2): 188.

Mylonakis E, Hohmann EL, Calderwood SB. Central nervous sys-tem infection with Listeria monocytogenes 33 years' experi-ence at a general hospital and review of 776 episodes from the literature. Medicine (Baltimore) 1998; 77(5): 313–36.

Charlier C, Perrodeau É, Leclercq A, Cazenave B, Pilmis B, Henry B, et al. Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study. Lancet Infect Dis 2017; 17(5): 510–9.

Seeliger H. Listeriose. In: Habs H, Kathe J. Beiträge zur Hygiene und Epidemiologie. Leipzig: Barth JA Verlag; 1955.

Duncan JM. Listeria and psychiatric syndromes. Br J Psychiatry 1989; 154: 887.

Kellner M, Sonntag A, Strian F. Psychiatric sequelae of listerio-sis. Br J Psychiatry 1990; 157: 299.

Nielsen H, Gyldensted C, Harmsen A. Cerebral abscess: aetiolo-gy and pathogenesis, symptoms, iagnosis and treatment. A re-view of 200 cases from 1935-1976. Acta Neurol Scand 1982; 65(6): 609–22.

Dee RR, Lorber B. Brain abscess due to Listeria monocyto-genes: case report and literature review. Rev Infect Dis 1986; 8(6): 968–77.

Antal EA, Loberg EM, Bracht P, Melby KK, Maehlen J. Evidence for intraaxonal spread of Listeria monocytogenes from the pe-riphery to the central nervous system. Brain Pathol 2001; 11(4): 432–8.

Michelet C, Leib SL, Bentue-Ferrer D, Täuber MG. Comparative efficacies of antibiotics in a rat model of meningoencephalitis due to Listeria monocytogenes. Antimicrob Agents Chemoth-er 1999; 43(7): 1651–6.

Patel K, Clifford DB. Bacterial brain abscess. The Neurohospi-talist 2014; 4(4): 196–204.

Rouquette C, Berche P. The pathogenesis of infection by Listeria monocytogenes. Microbiologia 1996; 12(2): 245–58.

Reynaud L, Graf M, Gentile I, Cerini R, Ciampi R, Noce S, et al. A rare case of brainstem encephalitis by Listeria monocyto-genes with isolated mesencephalic localization. Case report and review. Diagn Microbiol Infect Dis 2007; 58: 121–3.

Join-Lambert OF, Ezine S, Le Monnier A, Jaubert F, Okabe M, Berche P, et al. Listeria monocytogenes-infected bone marrow myeloid cells promote bacterial invasion of the central nerv-ous system. Cell Microbiol 2005; 7(2): 167–80.

Marget W, Seeliger HP. Listeria monocytogenes infections: therapeutic possibilities and problems. Infection 1988; 16(Suppl 2): S175–7.

Lorber B. Listeriosis. Clin Infect Dis 1997; 24(1): 1–9; quiz 10–1.

Temple ME, Nahata MC. Treatment of Listeriosis. Ann Phar-macother 2000; 34(5): 656–61.

Spitzer PG, Hammer SM, Karchmer AW. Treatment of Listeria monocytogenes infection with trimethoprim-sulfamethoxazole: case report and review of the literature. Rev Infect Dis 1986; 8(3): 427–30.

Wacker P, Ozsahin H, Groll AH, Gervaix A, Reinhard L, Hum-bert J. Trimethoprim-sulfamethoxazole salvage for refractory listeriosis during maintenance chemotherapy for acute lym-phoblastic leukemia. J Pediatr Hematol Oncol 2000; 22(4): 340–3.

Al-Khatti AA, Al-Tawfiq JA. Listeria monocytogenes brain ab-scess in a patient with multiple myeloma. J Infect Dev Ctries 2010; 4(12): 849–51.

Polat M, Kara SS, Tapısız A, Derinöz O, Çağlar K, Tezer H. Suc-cessful treatment of refractory listeria meningitis and bactere-mia with trimethoprim-sulfamethoxazole in an immunocom-petent child. Turkish J Pediatr 2016; 58(2): 220–2.

Merle-Melet M, Dossou-Gbete L, Maurer P, Meyer P, Lozniewski A, Kuntzburger O, et al. Is amoxicillin-cotrimoxazole the most appropriate antibiotic regimen for listeria meningoencephali-tis? Review of 22 cases and the literature. J Infect 1996; 33(2): 79–85.

Beach JE, Perrott J, Turgeon RD, Ensom MH. Penetration of vancomycin into the cerebrospinal fluid: a systematic review. Clin Pharmacokinet 2017; 56(12): 1479–90.

Pagliano P, Arslan F, Ascione T. Epidemiology and treatment of the commonest form of listeriosis: meningitis and bacteraemia. Infez Med 2017; 25(3): 210–6.